|
|||||
|
|
Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients |
|
| Authors: | Olga Mill n,Pablo Ruiz,Virginia Fortuna,Miquel Navasa,Merc Brunet |
| Affiliation: | Olga Millán,Pablo Ruiz,Virginia Fortuna,Miquel Navasa,Mercè Brunet |
| Abstract: | |
| Keywords: | calcineurin inhibitors CMV liver transplantation NFAT‐regulated gene expression intralymphocytary cytokines subclinical rejection T cell‐mediated acute rejection |